Modella AI pricing
There is no clinical commercial product to price yet. PathChat DX holds FDA Breakthrough Device Designation, which is a review pathway rather than a clearance, and PathChat 2a is research use only. The company states that the designation does not imply clearance or approval. No price, unit of charge or license term is published for the research tools.
How Modella AI pricing works
- Pricing model
- Undisclosed. PathChat DX, the version intended for clinical use, is pre market; the generally available PathChat 2a is research use only.
- Implementation
- Not disclosed. Operates as a generative copilot on whole slide images; specific deployment terms are not published.
Modella AI pricing against its alternatives
Published prices for Modella AI and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- MModella AIResearch use only, not commercially priced for clinical use
- PPaigeNot published (owned by Tempus since August 2025)
- AaetherAINo published price
- NNucleaiNo published price
- PPathAINo published price
- TTechcyteNo published price
- IImagene AINo published price
- AAccurKardiaNo published price
- MMednitionNo published price
Modella AI pricing, answered
How much does Modella AI cost?
Research use only, not commercially priced for clinical use. There is no clinical commercial product to price yet. PathChat DX holds FDA Breakthrough Device Designation, which is a review pathway rather than a clearance, and PathChat 2a is research use only.
Does Modella AI charge an implementation fee?
Not disclosed. Operates as a generative copilot on whole slide images; specific deployment terms are not published.